FDA
approval
· 2025-12-15
FDA Approved: BUPRENORPHINE AND NALOXONE — Original Application (Camber Pharmaceuticals, Inc.)
Summary
FDA approved Camber Pharmaceuticals' generic buprenorphine/naloxone product via an Original Application (ANDA).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for BUPRENORPHINE AND NALOXONE (BUPRENORPHINE AND NALOXONE)